DYN
Dyne Therapeutics Inc.
Company Overview
| Mkt Cap | $1.87B | Price | $22.58 |
| Volume | 3.00M | Change | -4.12% |
| P/E Ratio | -5.9 | Open | $23.21 |
| Revenue | -- | Prev Close | $23.55 |
| Net Income | $-317.4M | 52W Range | $6.36 - $35.68 |
| Div Yield | N/A | Target | $34.76 |
| Overall | 67 | Value | 60 |
| Quality | -- | Technical | 75 |
No chart data available
Stock Overview
Updated DailyDyne Therapeutics Inc. (DYN) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $22.58 with a market capitalization of $1.87 billion. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows DYN with a volume of 3.00 million shares. The stock opened down 1.44% from yesterday's close of $23.55. Current analyst estimates project earnings of $-3.58 per share for this year, with next year targeting $-3.39.
DYN demonstrates strong technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including NRG, AES, ALE, CNP.
Key investment considerations for DYN include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 53.9%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:32 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DYN | $22.58 | -4.1% | 3.00M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |